AbCheck s. r. o.

With a lean and agile team of experts boasting over 20 years of expertise in the field, AbCheck is equipped to tackle the most challenging targets and develop antibodies with therapeutically relevant biological functions. Using their proprietary platforms, AbCheck discovers and optimizes human antibodies through a range of cutting-edge technologies, including phage/yeast display libraries, mass humanization, antibody optimization, and microfluidics. This allows them to provide high-quality leads tailored to each partner's specific needs.

AbCheck offers a variety of services and technologies to meet the demands of the antibody discovery world. They excel in epitope-specific targeting, broad epitope coverage, isoform-specific antibodies, functional antibodies, species cross-reactivity, special stability requirements, and picomolar affinities. The management team at AbCheck comprises experienced professionals with diverse backgrounds in biotechnology development and commercialization.

Together, they ensure the highest quality standards and foster a close working relationship with clients. If you're looking for customized solutions and novel approaches in therapeutic antibody discovery and development, AbCheck is the ideal partner. Join forces with them to discover tailored solutions that deliver optimal results